ArticleScientific reports2018
Magnetite-Gold nanohybrids as ideal all-in-one platforms for theranostics.
Abstract read
In one paragraph
Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.
0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
38 citing papers in PubMed.
- pH-controlled reversible assembly of magnetic and plasmonic nanoparticles on gold nanorods.Nanoscale advances · 2026Article
- Resiquimod-loaded magnetic nanoparticles reprogram macrophages and induce oxidative cytotoxicity against triple-negative breast cancer cells.International journal of pharmaceutics: X · 2026Article
- Dimeric magnetic dumbbell nanoparticles with selective immobilization of chromophores for improved tumor theranostics.Scientific reports · 2026Article
- Development of manganese ferrite coated with Prussian blue as an efficient contrast agent for applications in magnetic resonance imaging.Scientific reports · 2025Article
- Characterization and antitumor effect of doxorubicin-loaded FeRSC advances · 2024Article
- A partial oxidation-based approach to the synthesis of gold-magnetite hybrid nanostructures.Scientific reports · 2024Article
- Carbon-Coated Iron Oxide Nanoparticles Promote Reductive Stress-Mediated Cytotoxic Autophagy in Drug-Induced Senescent Breast Cancer Cells.ACS applied materials & interfaces · 2024Article
- Development of Polymer-Encapsulated, Amine-Functionalized Zinc Ferrite Nanoparticles as MRI Contrast Agents.International journal of molecular sciences · 2023Article
- 3,4-Dihydroxiphenylacetic Acid-Based Universal Coating Technique for Magnetic Nanoparticles Stabilization for Biomedical Applications.Journal of functional biomaterials · 2023Article
- Metal and Metal Oxides Nanoparticles and Nanosystems in Anticancer and Antiviral Theragnostic Agents.Pharmaceutics · 2023Review
- The Combination of Photothermal Therapy and Chemotherapy using Alginate-Modified Iron Oxide-Gold Nanohybrids Carrying Cisplatin.Journal of biomedical physics & engineering · 2023Article
- Article
- Supermagnetic Human Serum Albumin (HSA) Nanoparticles and PLGA-Based Doxorubicin Nanoformulation: A Duet for Selective Nanotherapy.International journal of molecular sciences · 2022Article
- Synergistically Enhancing the Therapeutic Effect on Cancer, via Asymmetric Bioinspired Materials.Molecules (Basel, Switzerland) · 2022Review
- Synthesis of Biocompatible Superparamagnetic Iron Oxide Nanoparticles (SPION) under Different Microfluidic Regimes.ACS applied materials & interfaces · 2022Article
- From Structure to Function: Understanding Synthetic Conditions in Relation to Magnetic Properties of Hybrid Pd/Fe-Oxide Nanoparticles.Nanomaterials (Basel, Switzerland) · 2022Article
- Theranostic Applications of an Ultra-SensitiveCancers · 2022Article
- Star-Shaped Magnetic-Plasmonic Au@FeACS applied materials & interfaces · 2022Article
- Laser Synthesized Core-Satellite Fe-Au Nanoparticles for Multimodal In Vivo Imaging and In Vitro Photothermal Therapy.Pharmaceutics · 2022Article
- Iron-Gold Nanoflowers: A Promising Tool for Multimodal Imaging and Hyperthermia Therapy.Pharmaceutics · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Maria V EfremovaDepartment of Chemistry, Lomonosov Moscow State University, Moscow, 119991, Russian Federation.ORCID 0000-0002-5196-5596
Victor A NaumenkoNational University of Science and Technology «MISIS», Moscow, 119049, Russian Federation.
Marina SpasovaFaculty of Physics and Center for Nanointegration Duisburg-Essen, University of Duisburg-Essen, Duisburg, 47057, Germany.
Anastasiia S GaraninaDepartment of Chemistry, Lomonosov Moscow State University, Moscow, 119991, Russian Federation.ORCID 0000-0003-3442-9553
Maxim A AbakumovNational University of Science and Technology «MISIS», Moscow, 119049, Russian Federation.
Anastasia D BlokhinaDepartment of Chemistry, Lomonosov Moscow State University, Moscow, 119991, Russian Federation.
Pavel A MelnikovDepartment of Fundamental and Applied Neurobiology, Serbsky National Medical Research Center for Psychiatry and Narcology, Ministry of Health and Social Development of the Russian Federation, Moscow, 119034, Russian Federation.
Alexandra O PrelovskayaNational University of Science and Technology «MISIS», Moscow, 119049, Russian Federation.
Markus HeidelmannICAN - Interdisciplinary Center for Analytics on the Nanoscale and Center for Nanointegration Duisburg-Essen, University of Duisburg-Essen, Duisburg, 47057, Germany.
Zi-An LiFaculty of Physics and Center for Nanointegration Duisburg-Essen, University of Duisburg-Essen, Duisburg, 47057, Germany.
Zheng MaFaculty of Physics and Center for Nanointegration Duisburg-Essen, University of Duisburg-Essen, Duisburg, 47057, Germany.
Igor V ShchetininNational University of Science and Technology «MISIS», Moscow, 119049, Russian Federation.
Yuri I GolovinDepartment of Chemistry, Lomonosov Moscow State University, Moscow, 119991, Russian Federation.
Igor I KireevA.N. Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, 119991, Russian Federation.ORCID 0000-0001-9252-6808
Alexander G SavchenkoNational University of Science and Technology «MISIS», Moscow, 119049, Russian Federation.
Vladimir P ChekhoninDepartment of Medical Nanobiotechnology, Russian National Research Medical University, Moscow, 117997, Russian Federation.
Natalia L KlyachkoDepartment of Chemistry, Lomonosov Moscow State University, Moscow, 119991, Russian Federation.
Michael FarleFaculty of Physics and Center for Nanointegration Duisburg-Essen, University of Duisburg-Essen, Duisburg, 47057, Germany.
Alexander G MajougaDepartment of Chemistry, Lomonosov Moscow State University, Moscow, 119991, Russian Federation. rector@muctr.ru.
Ulf WiedwaldNational University of Science and Technology «MISIS», Moscow, 119049, Russian Federation. ulf.wiedwald@uni-due.de.ORCID 0000-0002-3209-4078
Funding
Russian Foundation for Basic Research (RFBR) 18-33-01232Russian Science Foundation (RSF) 17-14-01316
Abstract
High-quality, 25 nm octahedral-shaped Fe
Indexed as
Drug Delivery SystemsAnimalsCell Line, TumorDisease Models, AnimalFerrosoferric OxideGoldHymenopteraMagnetic Resonance ImagingMetal NanoparticlesMiceNeoplasms, ExperimentalParenteral Nutrition SolutionsTheranostic NanomedicineFerrosoferric OxideGoldParenteral Nutrition Solutions
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.